Cainap Calin
Cainap Calin
MD Phd Sef Lucrari
Adresă de e-mail confirmată pe
Citat de
Citat de
Phase III trial of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC).
C Cainap, S Qin, WT Huang, IJ Chung, H Pan, Y Cheng, M Kudo, ...
Journal of Clinical Oncology 31 (4_suppl), 249-249, 2013
Pain Palliation by Endoscopic Ultrasound-Guided Celiac PlexusNeurolysis in Patients with Unresectable Pancreatic Cancer.
A Seicean, C Cainap, I Gulei, M Tantau, R Seicean
Journal of Gastrointestinal & Liver Diseases 22 (1), 2013
Classic tumor markers in gastric cancer. Current standards and limitations
C Căinap, V Nagy, A Gherman, S Cetean, I Laszlo, AM Constantin, ...
Clujul Medical 88 (2), 111, 2015
Sequencing of antiangiogenic agents in the treatment of metastatic colorectal cancer
JJ Lee, E Chu
Clinical colorectal cancer 13 (3), 135-144, 2014
The importance of the granulocyte-colony stimulating factor in oncology
S Cetean, C Căinap, AM Constantin, S Căinap, A Gherman, L OPREAN, ...
Clujul medical 88 (4), 468, 2015
Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancer
BH O'Neil, C Cainap, E Van Cutsem, V Gorbunova, CS Karapetis, J Berlin, ...
Clinical colorectal cancer 13 (3), 156-163. e2, 2014
The impact of miRNA in colorectal cancer progression and its liver metastases
O Balacescu, D Sur, C Cainap, S Visan, D Cruceriu, R Manzat-Saplacan, ...
International journal of molecular sciences 19 (12), 3711, 2018
Spectroscopic and DFT study of atenolol and metoprolol and their copper complexes
O Cozar, L Szabó, IB Cozar, N Leopold, L David, C Căinap, V Chiș
Journal of Molecular Structure 993 (1-3), 357-366, 2011
Principii de cancerologie generală
V Nagy
Curs pentru studenți. Cluj-Napoca: Editura Medicală Universitară Iuliu …, 2007
Hypersensitivity reactions to platinum derivatives: findings of new predictive markers
S Cetean, T Ciuleanu, DC Leucuta, C Cainap, AM Constantin, I Cazacu, ...
Journal of BU ON.: official journal of the Balkan Union of Oncology 20 (6 …, 2015
Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer
D Sur, A Havasi, C Cainap, G Samasca, C Burz, O Balacescu, I Lupan, ...
Journal of Clinical Medicine 9 (1), 182, 2020
Chemotherapy-induced cardiotoxicity in oncology drugs involved and clinical assessment
population 21, 32, 2016
Conformational landscape and low lying excited states of imatinib
E Vințeler, NF Stan, R Luchian, C Căinap, JPP Ramalho, V Chiș
Journal of Molecular Modeling 21 (4), 84, 2015
MiRNAs roles in the diagnosis, prognosis and treatment of colorectal cancer
DG Sur, M Colceriu, G Sur, C Aldea, C Silaghi, G Samasca, I Lupan, ...
Expert review of proteomics 16 (10), 851-856, 2019
The role of miRNA-31-3p and miR-31-5p in the anti-EGFR treatment efficacy of wild-type K-RAS metastatic colorectal cancer. Is it really the next best thing in miRNAs?
D Sur, C Cainap, C Burz, A Havasi, IC Chis, C Vlad, V Milosevic, ...
Journal of BU ON.: Official Journal of the Balkan Union of Oncology 24 (5 …, 2019
Molecular targeted treatment of metastatic colorectal cancer: The cardiovascular adverse effects of Bevacizumab and Cetuximab
A Gherman, C Căinap, AM Constantin, S Cetean, SS Căinap
Clujul Medical 90 (4), 377, 2017
The prognostic role of EBER in pediatric cancer
SS Căinap, B Fetică, R Buiga, C Căinap, AM Constantin, AS Șovrea
Rom J Morphol Embroyol 56 (4), 1269-77, 2015
Unusual skin metastasis in a patient with recurrent micropapillary serous ovarian carcinoma–a case report and review of the literature
P Achimaș-Cadariu, C Vlad, B Fetica, A Zgaia, C Cainap
Clujul Medical 88 (2), 237, 2015
EBV in pediatric neoplasia–intensity of infection as independent prognostic factor
S Căinap, A Răchisan, B Fetică, R Cosnarovici, E Mihut, G Popa, ...
Journal of medicine and life 5 (3), 280, 2012
Platinum derivatives: A multidisciplinary approach
S Gheorghe-Cetean, C Cainap, L Oprean, A Hangan, P Virag, ...
J. BUON 22, 568-577, 2017
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20